Clinical Trial Detail

NCT ID	NCT02824042
Title	Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Bayer
Indications	pancreatic adenocarcinoma fallopian tube cancer stomach cancer ovary epithelial cancer lung non-small cell carcinoma colon cancer peritoneum cancer peritoneal mesothelioma gastroesophageal adenocarcinoma cholangiocarcinoma malignant pleural mesothelioma thymic carcinoma triple-receptor negative breast cancer
Therapies	Anetumab ravtansine + Itraconazole Anetumab ravtansine
Age Groups:	adult senior